The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
- 7 June 2001
- journal article
- review article
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 101 (7) , 2019-2036
- https://doi.org/10.1021/cr000118y
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Comparison of 225actinium chelates: tissue distribution and radiotoxicityNuclear Medicine and Biology, 1999
- Treatment of lung tumor colonies with 90Y targeted to blood vessels: comparison with the α-particle emitter 213BiNuclear Medicine and Biology, 1999
- Vascular Targeted Radioimmunotherapy with 213Bi—An α-Particle EmitterNuclear Medicine and Biology, 1998
- The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing miceNuclear Medicine and Biology, 1997
- A charged-particle microbeam: II. A single-particle micro-collimation and detection system.International Journal of Radiation Biology, 1997
- Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapyNuclear Medicine and Biology, 1996
- Lethality and Mutagenesis of B Lymphocyte Progenitor Cells Following Exposure to α-particles and X-raysInternational Journal of Radiation Biology, 1994
- Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin and biotinNuclear Medicine and Biology, 1993
- The preparation and labeling of DTPA-coupled albuminThe International Journal of Applied Radiation and Isotopes, 1982
- Covalent attachment of chelating groups to macromoleculesBiochemical and Biophysical Research Communications, 1977